Bronchiectasis is a multidimensional disease and, therefore, its severity or prognosis cannot
be adequately quantified by analysing one single variable. The objective of the present …

Introduction There is a relative lack of information about the death rate and morbidity of non-
cystic fibrosis bronchiectasis and most studies are limited due to referral bias. We wanted to …

Introduction Bronchiectasis is a multidimensional disease associated with substantial
morbidity and mortality. Two disease-specific clinical prediction tools have been developed …

Rationale: The clinical presentation and prognosis of non–cystic fibrosis bronchiectasis are
both very heterogeneous. Objectives: To identify different clinical phenotypes for non–cystic …

Rationale: Testing for underlying etiology is a key part of bronchiectasis management, but it
is unclear whether the same extent of testing is required across the spectrum of disease …

The clinical course of bronchiectasis is unpredictable, posing a challenge both in clinical
practice and in research. Two mortality prediction scores, the bronchiectasis severity index …

Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …

Background Patients with bronchiectasis often have concurrent comorbidities, but the
nature, prevalence, and impact of these comorbidities on disease severity and outcome are …

Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …

Introduction There is limited data on mortality and associated morbidity in non-cystic fibrosis
bronchiectasis (NCFB). Our aim was to analyze the overall mortality for all newly diagnosed …